Skip to main content
Clinical Trials/CTRI/2025/01/078879
CTRI/2025/01/078879
Not yet recruiting
Phase 2

A Randomized Controlled Trial To Evaluate The Efficacy Of Lakshadigana kwatha karnaprakshalana and Rasanjana Madhu karnapoorna in comparison to Fluconazole 0.3 percent Ear drops In The Treatment Of kaphajkarnashoola - Otomycosis

Dr Abhilasha1 site in 1 country100 target enrollmentStarted: February 2, 2026Last updated:

Overview

Phase
Phase 2
Status
Not yet recruiting
Sponsor
Dr Abhilasha
Enrollment
100
Locations
1
Primary Endpoint
Improvement in the sign and the symptoms of the

Overview

Brief Summary

In the previous research done a significant result has been observed in treating the sign and the symptoms of the otomycosis using different Ayurvedic treatment modalities. Even after the extensive research work has been carried out, Otomycosis is still a challenging disease and remains one of the most established risk factor for the serious complications such as otorrhoea, tympanic perforations and deafness. Hence it is decided to continue the study on otomycosis so as to prove the efficacy of new Ayurvedic intervention and to study it on large population so as to generate more data to evaluate the efficacy of new Ayurveda drug in treating the Otomycosis

Study Design

Study Type
Interventional
Allocation
Coin toss, Lottery, toss of dice, shuffling cards etc
Masking
None

Eligibility Criteria

Ages
16.00 Year(s) to 60.00 Year(s) (—)
Sex
All

Inclusion Criteria

  • Patient presenting with sign and symptoms of otomycosis.
  • Lakshana of kaphajkarnashoola.
  • Patients willing to give conse.

Exclusion Criteria

  • Patient having perforated tympanic membrane.
  • Patient of CSOM and ASOM.
  • Patient suffering from systemic diseases like uncontrolled DM, HIV, Hypothyroidism.
  • Immunocompetent and immunocompromised.

Outcomes

Primary Outcomes

Improvement in the sign and the symptoms of the

Time Frame: 40 Days.

kaphajkarnashoola – Otomycosis is expected.

Time Frame: 40 Days.

Secondary Outcomes

No secondary outcomes reported

Investigators

Sponsor
Dr Abhilasha
Sponsor Class
Other [self]
Responsible Party
Principal Investigator
Principal Investigator

Dr Abhilasha

SKAU, Krukshetra

Study Sites (1)

Loading locations...

Similar Trials